טוען...
Longstanding insulin dependent diabetics may not require insulin after the introduction of GLP-1 analogues
Glucagon like peptide (GLP-1) analogues are a relatively novel medication developed primarily for the treatment of type 2 diabetes since 2005. Although GLP-1 analogues have been shown to be more effective in the first few years of diagnosis in type 2 diabetes, we report a case of a patient with long...
שמור ב:
| הוצא לאור ב: | JRSM Cardiovasc Dis |
|---|---|
| Main Authors: | , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
SAGE Publications
2015
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4359167/ https://ncbi.nlm.nih.gov/pubmed/26668738 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2048004015576008 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|